Concurrent Lepromatous Leprosy and Active Tuberculosis in A Young Male: A Complex Diagnostic and Therapeutic Challenge with Hematologic Manifestations

Main Article Content

Juan Fausto Martínez González
Ana Laura Ricarte González
Alma Elizabeth Díaz Gamiño
Leonel Castro López
Francisco Adrián Razo Moreno
Ana Victoria Pérez García
Mireya Nolasco Sanchez
Cristina Montserrat García Montalvo
Katia Gabriela Silva Esquivel
Mayra Aréchiga López
Alejandro Calderón Romo
Jonathan Guzmán Rodríguez
Ilse Nájera Basurto
Sergio Ronaldo Esparza Herrera
María José Soto Martínez
Karla Teresa Granados Velasco
Alexa Ximena Márquez Durón

Abstract

This report details the clinical evolution of a 23-year-old male presenting with the exceptionally rare co-occurrence of active lepromatous lerosy and tuberculous lymphadenitis, complicated by severe immune thrombocytopenia. The patient’s presentation—spanning chronic dermatological findings, acute systemic symptoms, and profound hematological disturbance—required a multifaceted diagnostic approach culminating in histopathological and microbiological confirmation of both mycobacterial infections. Management was successfully integrated, utilizing a single rifampin-based antitubercular regimen to simultaneously address both diseases, resulting in resolution of thrombocytopenia and significant clinical improvement. This case highlights the diagnostic complexity in co-endemic regions, the potential for tuberculosis to drive significant parainfectious hematologic complications, and the feasibility of a unified pharmacological strategy for dual mycobacterial disease.

Article Details

How to Cite
Martínez González, Juan Fausto, Ana Laura Ricarte González, Alma Elizabeth Díaz Gamiño, Leonel Castro López, Francisco Adrián Razo Moreno, Ana Victoria Pérez García, Mireya Nolasco Sanchez, Cristina Montserrat García Montalvo, Katia Gabriela Silva Esquivel, Mayra Aréchiga López, Alejandro Calderón Romo, Jonathan Guzmán Rodríguez, Ilse Nájera Basurto, Sergio Ronaldo Esparza Herrera, María José Soto Martínez, Karla Teresa Granados Velasco, and Alexa Ximena Márquez Durón. 2025. “Concurrent Lepromatous Leprosy and Active Tuberculosis in A Young Male: A Complex Diagnostic and Therapeutic Challenge With Hematologic Manifestations”. International Journal of Medical Science and Clinical Research Studies 5 (12):2058-62. https://doi.org/10.47191/ijmscrs/v5-i12-20.
Section
Articles

References

I. Kurz SG, Furin JJ, Bark CM. Drug-Resistant Tuberculosis: Challenges and Progress. Infect Dis Clin North Am. 2016;30(2):509–22.

doi: 10.1016/j.idc.2016.02.010

II. Narasimhan P, Wood J, Macintyre CR, Mathai D. Risk factors for tuberculosis. Pulm Med. 2013;2013:828939. 10.1155/2013/828939.

III. Pescarini JM, Strina A, Nery JS, Skalinski LM, Andrade KVF, Penna MLF, Brickley EB, Rodrigues LC, Barreto ML, Penna GO. Socioeconomic risk markers of leprosy in high-burden countries: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018 Jul 9;12(7):e0006622. 10.1371/journal.pntd.0006622.

IV. Parise-Fortes MR, Lastória JC, Marques SA, et al. Lepromatous leprosy and perianal tuberculosis: a case report and literature review. J Venom Anim Toxins Incl Trop Dis. 2014;20:38. 10.1186/1678-9199-20-38.

V. Trindadae M, Miyamoto D, Benard G, Sakai- valente N, Vasconcelos D, Naafs B. Case report: Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature. Am J Trop Med Hyg. 2013;88(2):236–40. doi: 10.4269/ajtmh.2012.12-0433.

VI. Massone C, Talhari C, Ribeiro-Rodrigues R, Sindeaux R, Mira M, Talhari s BN. Leprosy and HIV coinfection: a critical approach. Expert Rev Anti Infect Ther. 2011;9(6):701–10.

doi: 10.1586/eri.11.44.

VII. Lockwood D, Lambert S. Leprosy and HIV, where are we at? Lepr Rev. 2010;81(3):169–75.

doi: 10.47276/lr.81.3.169.

VIII. .Ustianowski A, Lawn S. Interactions between HIV infection and leprosy: a paradox. Lancet. 2006;6(6):350–60.

doi: 10.1016/S1473-3099(06)70493-5.

Most read articles by the same author(s)